Prelude Therapeutics Announces First Quarter 2021 Financial Results and Operations Update

NEXT STORY
LexaGene Expands its Sales Team
PREV STORY
Dermal Fillers Market Size 2021 | Is Likely to Reach USD 6.64 Billion by 2027, Registering a CAGR of 9.3%
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

At the Meet Novartis Management investor event, Novartis highlights strategy to focus the company and drive sustainable growth

Full pipeline of late stage assets with blockbuster potential Positioned to deliver sales growth ...

author_avatar
NASDAQ Market News

Junshi Biosciences Announces Approval of Supplemental New Drug Application by NMPA for Toripalimab in Combination with Cisplatin and Gemcitabine as First-Line Treatment for Patients with Locally Recurrent or Metastatic Nasopharyngeal Carcinoma

author_avatar
NASDAQ Market News

FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

FIT Biotech Oy Company release December 29, 2017 at 11:30 AM EET Conversion of ...

author_avatar
NASDAQ Market News